738 related articles for article (PubMed ID: 34305920)
1. A Pan-Cancer Analysis of CD161, a Potential New Immune Checkpoint.
Zhou X; Du J; Liu C; Zeng H; Chen Y; Liu L; Wu D
Front Immunol; 2021; 12():688215. PubMed ID: 34305920
[TBL] [Abstract][Full Text] [Related]
2. A pan-cancer analysis of RNASEH1, a potential regulator of the tumor microenvironment.
Yi C; Yang J; Zhang T; Xie S; Li W; Qin L; Chen D
Clin Transl Oncol; 2023 Aug; 25(8):2569-2586. PubMed ID: 37022517
[TBL] [Abstract][Full Text] [Related]
3. Clinical characterization and immunosuppressive regulation of CD161 (KLRB1) in glioma through 916 samples.
Di W; Fan W; Wu F; Shi Z; Wang Z; Yu M; Zhai Y; Chang Y; Pan C; Li G; Kahlert UD; Zhang W
Cancer Sci; 2022 Feb; 113(2):756-769. PubMed ID: 34881489
[TBL] [Abstract][Full Text] [Related]
4. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
Zhang X; Wang Y; A G; Qu C; Chen J
Front Immunol; 2021; 12():721030. PubMed ID: 34531868
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory CD161 receptor identified in glioma-infiltrating T cells by single-cell analysis.
Mathewson ND; Ashenberg O; Tirosh I; Gritsch S; Perez EM; Marx S; Jerby-Arnon L; Chanoch-Myers R; Hara T; Richman AR; Ito Y; Pyrdol J; Friedrich M; Schumann K; Poitras MJ; Gokhale PC; Gonzalez Castro LN; Shore ME; Hebert CM; Shaw B; Cahill HL; Drummond M; Zhang W; Olawoyin O; Wakimoto H; Rozenblatt-Rosen O; Brastianos PK; Liu XS; Jones PS; Cahill DP; Frosch MP; Louis DN; Freeman GJ; Ligon KL; Marson A; Chiocca EA; Reardon DA; Regev A; Suvà ML; Wucherpfennig KW
Cell; 2021 Mar; 184(5):1281-1298.e26. PubMed ID: 33592174
[TBL] [Abstract][Full Text] [Related]
6. Characterization of Exosome-Related Gene Risk Model to Evaluate the Tumor Immune Microenvironment and Predict Prognosis in Triple-Negative Breast Cancer.
Qiu P; Guo Q; Yao Q; Chen J; Lin J
Front Immunol; 2021; 12():736030. PubMed ID: 34659224
[TBL] [Abstract][Full Text] [Related]
7. Pan-cancer analysis of N4-acetylcytidine adaptor THUMPD1 as a predictor for prognosis and immunotherapy.
Li K; Liu J; Yang X; Tu Z; Huang K; Zhu X
Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34762107
[TBL] [Abstract][Full Text] [Related]
8. Systematic Pan-Cancer Analysis of KLRB1 with Prognostic Value and Immunological Activity across Human Tumors.
Cheng X; Cao Y; Wang X; Cheng L; Liu Y; Lei J; Peng W; Shi D
J Immunol Res; 2022; 2022():5254911. PubMed ID: 35028320
[TBL] [Abstract][Full Text] [Related]
9. CD161, a promising Immune Checkpoint, correlates with Patient Prognosis: A Pan-cancer Analysis.
Ye W; Luo C; Li C; Liu Z; Liu F
J Cancer; 2021; 12(21):6588-6599. PubMed ID: 34659549
[No Abstract] [Full Text] [Related]
10. PNOC Expressed by B Cells in Cholangiocarcinoma Was Survival Related and LAIR2 Could Be a T Cell Exhaustion Biomarker in Tumor Microenvironment: Characterization of Immune Microenvironment Combining Single-Cell and Bulk Sequencing Technology.
Chen Z; Yu M; Yan J; Guo L; Zhang B; Liu S; Lei J; Zhang W; Zhou B; Gao J; Yang Z; Li X; Zhou J; Fan J; Ye Q; Li H; Xu Y; Xiao Y
Front Immunol; 2021; 12():647209. PubMed ID: 33841428
[TBL] [Abstract][Full Text] [Related]
11. High gene expression of estrogen and progesterone receptors is associated with decreased t cell infiltration in patients with NSCLC.
Oh MS; Anker JF; Chae YK
Cancer Treat Res Commun; 2021; 27():100317. PubMed ID: 33711637
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive analyses of the heterogeneity and prognostic significance of tumor-infiltrating immune cells in non-small-cell lung cancer: Development and validation of an individualized prognostic model.
Pang Z; Chen X; Wang Y; Wang Y; Yan T; Wan J; Du J
Int Immunopharmacol; 2020 Sep; 86():106744. PubMed ID: 32623229
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive Transcriptomic Analysis Reveals the Role of the Immune Checkpoint HLA-G Molecule in Cancers.
Xu HH; Gan J; Xu DP; Li L; Yan WH
Front Immunol; 2021; 12():614773. PubMed ID: 34276642
[TBL] [Abstract][Full Text] [Related]
14. Construction of an immune-related gene signature for prediction of prognosis in patients with cervical cancer.
Mei J; Xing Y; Lv J; Gu D; Pan J; Zhang Y; Liu J
Int Immunopharmacol; 2020 Nov; 88():106882. PubMed ID: 32799114
[TBL] [Abstract][Full Text] [Related]
15. Identification of LOXL3-associating immune infiltration landscape and prognostic value in hepatocellular carcinoma.
Wang N; Zhou X; Tang F; Wang X; Zhu X
Virchows Arch; 2021 Dec; 479(6):1153-1165. PubMed ID: 34448895
[TBL] [Abstract][Full Text] [Related]
16. CMTM3 as a Potential New Immune Checkpoint Regulator.
Shen Q; Cong Z; Zhou Y; Teng Y; Gao J; Tang W
J Oncol; 2022; 2022():2103515. PubMed ID: 36245970
[TBL] [Abstract][Full Text] [Related]
17. Construction of a five-gene prognostic model based on immune-related genes for the prediction of survival in pancreatic cancer.
Liu B; Fu T; He P; Du C; Xu K
Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34143198
[TBL] [Abstract][Full Text] [Related]
18. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study.
Sun R; Limkin EJ; Vakalopoulou M; Dercle L; Champiat S; Han SR; Verlingue L; Brandao D; Lancia A; Ammari S; Hollebecque A; Scoazec JY; Marabelle A; Massard C; Soria JC; Robert C; Paragios N; Deutsch E; Ferté C
Lancet Oncol; 2018 Sep; 19(9):1180-1191. PubMed ID: 30120041
[TBL] [Abstract][Full Text] [Related]
19. Molecular and Clinical Characterization of PD-1 in Breast Cancer Using Large-Scale Transcriptome Data.
Liu Q; Cheng R; Kong X; Wang Z; Fang Y; Wang J
Front Immunol; 2020; 11():558757. PubMed ID: 33329517
[TBL] [Abstract][Full Text] [Related]
20. Cytolytic activity score as a biomarker for antitumor immunity and clinical outcome in patients with gastric cancer.
Hu Q; Nonaka K; Wakiyama H; Miyashita Y; Fujimoto Y; Jogo T; Hokonohara K; Nakanishi R; Hisamatsu Y; Ando K; Kimura Y; Masuda T; Oki E; Mimori K; Oda Y; Mori M
Cancer Med; 2021 May; 10(9):3129-3138. PubMed ID: 33769705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]